目的探讨晚期肝门部胆管癌患者经皮经肝门静脉栓塞术的护理。
Objective: Researching the effect of applying selective portal vein embolization (SPVE) in the primary hepatic carcinoma patients.
目的研究肝动脉化疗栓塞基础上经皮经肝门静脉灌注化疗治疗晚期肝癌的疗效。
Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).
结论：经间接门静脉灌注可作为直接门静脉灌注的一个补充手段应用于肝肿瘤的“双灌注”治疗。
CONCLUSIONS Intra indirect portal vein perfusion can be apply to dual perfusion treatment of liver tumors as a supplementing means of portal vein perfusion.
目的探讨经导管门静脉栓塞（PVE）诱导肝叶代偿性增生临床应用的可行性、安全性、有效性。
Objective To evaluate the clinical feasibility, safety, and effectiveness of transcatheter portal vein embolization (PVE) inducing compensatory hypertrophy of the remnant liver.
目的研究经颈静脉途径肝内门体静脉内支架分流术TIPS S术后肝性脑病的发生与门静脉血流方向的关系。
Objective: to study the relationship between hepatic encephalopathy and blood flow direction of intra hepatic portal vein after transjugular intrahepatic portosystemic stent shunt (TIPSS).
目的探讨通过超声引导经皮肝穿途径向门脉内放置内支架治疗癌栓引起的门静脉高压的效果。
Objective To evaluate the treatment of portal hypertension caused by tumor thrombi with percutaneous transhepatic portal vein stent implantation under the US guidance.
目的探讨通过超声引导经皮肝穿途径向门脉内放置内支架治疗癌栓引起的门静脉高压的效果。
Objective To evaluate the treatment of portal hypertension caused by tumor thrombi with percutaneous transhepatic portal vein stent implantation under the US guidance.
应用推荐